$182.10
1.75[0.97%]
At close: Mar 28
$182.10
0[0.00%]
After Hours: 6:04PM EDT
AbbVie reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of AbbVie using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
04/25/2024 | AM | ABBV | Q1 | $2.46 | $2.34 | — | — | $12.22B | $11.97B | — | — | Get Alert |
02/02/2024 | AM | ABBV | Q4 | $3.60 | $2.77 | $2.79 | 0.72% | $15.12B | $14.02B | $14.30B | 2.00% | Get Alert |
10/27/2023 | AM | ABBV | Q3 | $3.66 | $2.86 | $2.95 | 3.15% | $14.81B | $13.70B | $13.93B | 1.66% | Get Alert |
07/27/2023 | AM | ABBV | Q2 | $3.37 | $2.80 | $2.91 | 3.93% | $14.58B | $13.52B | $13.87B | 2.55% | Get Alert |
04/27/2023 | AM | ABBV | Q1 | $3.16 | $2.46 | $2.46 | 0.00% | $13.54B | $12.17B | $12.22B | 0.45% | Get Alert |
02/09/2023 | AM | ABBV | Q4 | $3.08 | $3.56 | $3.60 | 1.12% | $14.89B | $15.31B | $15.12B | -1.23% | Get Alert |
10/28/2022 | AM | ABBV | Q3 | $2.83 | $3.59 | $3.66 | 1.95% | $14.34B | $14.96B | $14.81B | -0.99% | Get Alert |
07/29/2022 | AM | ABBV | Q2 | $3.11 | $3.33 | $3.37 | 1.20% | $13.96B | $14.62B | $14.58B | -0.25% | Get Alert |
04/29/2022 | AM | ABBV | Q1 | $2.95 | $3.14 | $3.16 | 0.64% | $13.01B | $13.63B | $13.54B | -0.67% | Get Alert |
02/02/2022 | AM | ABBV | Q4 | $2.92 | $3.28 | $3.31 | 0.91% | $13.86B | $14.98B | $14.89B | -0.63% | Get Alert |
10/29/2021 | AM | ABBV | Q3 | $2.83 | $3.22 | $3.33 | 3.42% | $12.90B | $14.32B | $14.34B | 0.15% | Get Alert |
07/30/2021 | AM | ABBV | Q2 | $2.34 | $3.09 | $3.11 | 0.65% | $10.43B | $13.63B | $13.96B | 2.41% | Get Alert |
04/30/2021 | AM | ABBV | Q1 | $2.42 | $2.83 | $2.95 | 4.24% | $8.62B | $12.76B | $13.01B | 1.96% | Get Alert |
02/03/2021 | AM | ABBV | Q4 | $2.21 | $2.85 | $2.92 | 2.46% | $8.70B | $13.70B | $13.86B | 1.15% | Get Alert |
10/30/2020 | AM | ABBV | Q3 | $2.33 | $2.76 | $2.83 | 2.54% | $8.48B | $12.72B | $12.90B | 1.43% | Get Alert |
07/31/2020 | AM | ABBV | Q2 | $2.26 | $2.19 | $2.34 | 6.85% | $8.26B | $10.08B | $10.43B | 3.42% | Get Alert |
05/01/2020 | AM | ABBV | Q1 | $2.14 | $2.25 | $2.42 | 7.56% | $7.83B | $8.33B | $8.62B | 3.47% | Get Alert |
02/07/2020 | AM | ABBV | Q4 | $1.90 | $2.19 | $2.21 | 0.91% | $8.30B | $8.70B | $8.70B | 0.05% | Get Alert |
11/01/2019 | AM | ABBV | Q3 | $2.14 | $2.30 | $2.33 | 1.30% | $8.24B | $8.38B | $8.48B | 1.18% | Get Alert |
AbbVie (ABBV) is scheduled to report earnings on April 25, 2024. The last reported earnings were for reported on February 2, 2024 for Q4.
The Actual EPS was $2.79, which beat the estimate of $2.77.
The Actual Revenue was $14.3B, which beat the estimate of $14B.
Browse earnings estimates, EPS, and revenue on all stocks.